Recent trends in drug shortages: An update from the 2003 report

American Journal of Health-System Pharmacy

Volumn 66, Issue 9, 2009, Pages 798-800

  Fox, Erin ^a   Tyler, Linda S ^a  

^a UNIVERSITY OF UTAH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDRALAZINE; MEROPENEM; PANTOPRAZOLE; PIPERACILLIN PLUS TAZOBACTAM; PROTAMINE; RABIES IMMUNOGLOBULIN; THIAMINE;

ARTICLE; DRUG APPROVAL; DRUG INFORMATION; DRUG MANUFACTURE; DRUG RESEARCH; DRUG SHORTAGE; HEALTH CARE SYSTEM; PRIORITY JOURNAL;

EID: 66149185328     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp080314     Document Type: Article

References (7)

1. Fox ER, Tyler LS. Managing drug shortages: seven years' experience at one health system. Am J Health-Syst Pharm. 2003; 60:245-53.
2. McEvoy GK, ed. AHFS Drug Information 2008. Bethesda, MD: American Society of Health-System Pharmacists; 2008:vii-x.
3. Food and Drug Administration. Guidance for FDA staff and industry. Marketed unapproved drugs - compliance policy guide. www.fda.gov/cder/guidance/ 6911 fnl.pdf (accessed 2008 Apr 14).
4. Food and Drug Administration. Questions and answers on the unapproved drug compliance policy guide (CPG). www.fda. gov/cder/compliance/CPG-QandA.htm (accessed 2008 Apr 14).
5. Schweitzer SO. Trying times at the FDA-the challenge of ensuring the safety of imported pharmaceuticals. N Engl J Med. 2008; 358:1773-7.
6. Barkes K. China plant implicated in heparin scare "never" inspected by FDA. www.outsourcing-pharma.com/Contract-Manufacturing/China-plant- implicated-in-heparin-scare-never-inspected-by-FDA (accessed 2009 Feb 11).
7. Wood AJ. Playing "kick the FDA'-risk-free to players but hazardous to public health. N Engl J Med. 2008; 358:1774-5.